6,108 results on '"GASBARRINI, Antonio"'
Search Results
2. A single bout of physical exercise improves 1-hour post-load plasma glucose in healthy young adults
3. Clinical characteristics and prognostic impact of atrial fibrillation among older patients with heart failure with preserved ejection fraction hospitalized for acute heart failure
4. Prognostic value of liver stiffness in patients hospitalized for acute decompensated heart failure: a meta-analysis
5. Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma
6. Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients
7. List of contributors
8. Current treatments of alcohol use disorder
9. Medical treatments and follow-up for clinical conditions associated to celiac disease
10. Beta-cell function and glucose metabolism in patients with chronic pancreatitis
11. The interplay of extracellular vesicles in the pathogenesis of metabolic impairment and type 2 diabetes
12. Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)
13. Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study
14. Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care
15. Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis
16. The Clinical Frailty Scale (CFS) as an Independent Prognostic Factor for Patients ≥80 Years with Small Bowel Obstruction (SBO)
17. Is there a role for microbiome-based approach in common variable immunodeficiency?
18. Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves
19. A single-center prospective analysis of the impact of glucose metabolism on pancreatic fistula onset after pancreaticoduodenectomy for periampullary tumors
20. The role of procalcitonin as a risk stratification tool of severity, prognosis, and need for surgery in patients with acute left-sided colonic diverticulitis
21. Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study
22. Impact of body composition parameters on radiation therapy compliance in locally advanced rectal cancer: A retrospective observational analysis
23. Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease – A comprehensive narrative review
24. Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics
25. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
26. Author Correction: Comparison of the management of Helicobacter pylori infection between the older and younger European populations
27. Comparison of the management of Helicobacter pylori infection between the older and younger European populations
28. Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (CLTI): a prospective study
29. The role of Klotho and FGF23 in cardiovascular outcomes of diabetic patients with chronic limb threatening ischemia: a prospective study
30. Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes
31. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
32. Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
33. The role of microbiome in the development of gluten-related disorders
34. Gut microbiota in colorectal cancer: From pathogenesis to clinic
35. Gut microbiota in inflammation and colorectal cancer: A potential Toolbox for Clinicians
36. Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeutics
37. The microbiome-driven impact of western diet in the development of noncommunicable chronic disorders
38. The role of faecal microbiota transplantation in chronic noncommunicable disorders
39. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis
40. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis
41. Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies
42. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
43. Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals
44. An undetectable source of recurrent gastrointestinal bleeding: hemosuccus pancreaticus
45. Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
46. Predicting ICU admission and death in the Emergency Department: A comparison of six early warning scores
47. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience
48. Radiomics could predict surgery at 10 years in Crohn's disease
49. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs
50. An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.